GSE227747

Transcriptome Profiling of Intact Bowel Wall Reveals that PDE1A and SEMA3D are Possible Markers with Roles in Enteric Smooth Muscle Apoptosis, Proliferative Disorders, and Autonomic Nervous Abnormality in Crohn's Disease.

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

10 case / 5 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Summary

To use surgical resection specimens of the intact bowel wall from inflammatory bowel disease (IBD) patients and perform RNA-seq, bioinformatics analysis, and validation by quantitative polymerase chain reaction (qPCR) and immunohistochemistry (IHC) to explore the subtle differences between Crohn's disease (CD) and ulcerative colitis (UC), with predominant focus on the smooth muscle cells (SMCs) and enteric autonomic nervous system (ANS).

Overall design

The intact colon specimens from IBD surgical patients were divided based on their inflammatory status into inflamed (6 iCD, 6 iUC) and non-inflamed (6 niBD: 3 niCD+3 niUC) groups

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
15 GSM samples
Primary source
recount3

Planned trusted source for processed count availability.

No match found
Expression Atlas

Planned source for curated expression experiment links.

No match found
PubMed

Primary GEO citations and related PubMed articles that mention this dataset.

1 linked publication 1 DOI

Primary publication

  1. Transcriptome profiling of intact bowel wall reveals that PDE1A and SEMA3D are possible markers with roles in enteric smooth muscle apoptosis, proliferative disorders, and dysautonomia in Crohn's disease. Frontiers in genetics, 2023
Available

Metadata Quality Components

Analysis Readiness

Ready after review
97% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

7/10 pts

Warnings are present, but none are critical blockers.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No readiness blockers detected.

Next Steps

  • Verify the proposed sample assignments and case-versus-control comparison against the GEO metadata before using them in DESeq2 or another differential-expression tool.
  • Confirm processed count files and sample identifiers match the exported metadata.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Standard analyst review

Proceed only after the analyst confirms grouping, exclusions, and source files.

By Siftome standards, no expert review was triggered.

Why This Is Ranked Here

Tumor vs normal
Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Disease context Crohn's disease, colorectal cancer, inflammatory bowel disease, ulcerative colitis Disease context came from Normalization rules.
  • Likely case group Crohn's disease 10 samples
  • Likely control group Non-inflamed tissue 5 samples

Ranking Facts

Supporting evidence

  • Comparison: Disease/model vs control. Specimen: Tissue. Comparison suitability: 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Crohn's disease, Inflammatory bowel disease, Ulcerative colitis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 37727374.
  • Publication context: Transcriptome profiling of intact bowel wall reveals that PDE1A and SEMA3D are possible markers with roles in enteric smooth muscle apoptosis, proliferative disorders, and dysautonomia in Crohn's disease.. Frontiers in genetics, 2023. PMID 37727374. DOI 10.3389/fgene.2023.1194882.

Cautions

  • Disease/control design without a tumor/normal comparison is outside tumor/normal triage.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

Normalized Fields

52 fields

Sample Group Preview

15 rows shown
Show Hide
Study totals: Case 10 | Control 5 | Unassigned 0 | Excluded 0 | Ambiguous 0 15 rows shown
Group Role Accession Title Source / characteristics Reason
Crohn's disease Case GSM7106751 iCD1, male, 32 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Crohn’s disease Case marker detected.
Crohn's disease Case GSM7106752 iCD2, male, 23 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Crohn’s disease Case marker detected.
Crohn's disease Case GSM7106753 iCD3, male, 24 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Crohn’s disease Case marker detected.
Crohn's disease Case GSM7106754 iCD5, male, 46 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Crohn’s disease Case marker detected.
Crohn's disease Case GSM7106755 iCD6, male, 25 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Crohn’s disease Case marker detected.
Ulcerative colitis Case GSM7106761 iUC1, male, 65 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Ulcerative colitis Case marker detected.
Ulcerative colitis Case GSM7106762 iUC2, male, 75 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Ulcerative colitis Case marker detected.
Ulcerative colitis Case GSM7106763 iUC3, male, 67 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Ulcerative colitis Case marker detected.
Ulcerative colitis Case GSM7106764 iUC4, male, 56 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Ulcerative colitis Case marker detected.
Ulcerative colitis Case GSM7106765 iUC5, male, 67 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Ulcerative colitis Case marker detected.
Non-inflamed tissue Control GSM7106756 NiBD1, male, 32 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Non-inflamed colon Control marker detected.
Non-inflamed tissue Control GSM7106757 NiBD2, male, 23 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Non-inflamed colon Control marker detected.
Non-inflamed tissue Control GSM7106758 NiBD3, male, 24 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Non-inflamed colon Control marker detected.
Non-inflamed tissue Control GSM7106759 NiBD4, male, 56 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Non-inflamed colon Control marker detected.
Non-inflamed tissue Control GSM7106760 NiBD5, male, 67 years old Colon, intact bowel wall Tissue: Colon, intact bowel wall; Disease state: Non-inflamed colon Control marker detected.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.